Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

ALDX – Aldeyra Therapeutics, Inc.

Aldeyra Therapeutics, Inc.
ALDX
$0.651
Name : Aldeyra Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $39,316,252.00
EPSttm : -0.31
finviz dynamic chart for ALDX
Aldeyra Therapeutics, Inc.
$0.651
3.54%
$0.022
ALDX — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

5.44

Margin Of Safety %

Put/Call OI Ratio

0.41

EPS Next Q Diff

EPS Last/This Y

0.22

EPS This/Next Y

0.06

Price

0.65

Target Price

6.6

Analyst Recom

1.4

Performance Q

-54.76

Upside

-1,823.1%

Beta

1.27

Ticker: ALDX




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-10-13ALDX0.89980.170.243936
2026-10-14ALDX0.79050.1715.633973
2026-10-15ALDX0.74020.420.194872
2026-10-16ALDX0.70.420.184876
2026-10-19ALDX0.66510.540.043904
2026-10-20ALDX0.72460.530.603988
2026-10-21ALDX0.67660.530.003993
2026-10-22ALDX0.63730.534.003998
2026-10-23ALDX0.64970.541.284036
2026-10-26ALDX0.65040.570.023791
2026-10-27ALDX0.63030.500.004134
2026-10-28ALDX0.690.496.504182
2026-10-29ALDX0.65960.490.264192
2026-10-30ALDX0.56010.48999.994225
2026-11-02ALDX0.59210.49999.993824
2026-11-03ALDX0.62710.460.064003
2026-11-04ALDX0.65220.450.034026
2026-11-05ALDX0.61780.430.754154
2026-11-06ALDX0.63680.430.004164
2026-11-09ALDX0.63010.420.194249
2026-11-10ALDX0.62730.410.004274
2026-11-11ALDX0.64660.410.094275
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-10-13ALDX0.8928.9- -0.34
2026-10-14ALDX0.7928.9- -0.34
2026-10-15ALDX0.7428.9- -0.34
2026-10-16ALDX0.7028.9- -0.34
2026-10-19ALDX0.6728.9- -0.34
2026-10-20ALDX0.6728.9- -0.34
2026-10-21ALDX0.7328.9- -0.34
2026-10-22ALDX0.6428.9- -0.34
2026-10-23ALDX0.6528.9- -0.34
2026-10-26ALDX0.6528.9- -0.34
2026-10-27ALDX0.6428.9- -0.34
2026-10-28ALDX0.6928.9- -0.34
2026-10-29ALDX0.6628.9- -0.34
2026-10-30ALDX0.5628.9- -0.34
2026-11-02ALDX0.5828.9- -0.34
2026-11-03ALDX0.6328.9- -0.34
2026-11-04ALDX0.6528.9- -0.34
2026-11-05ALDX0.6228.9- -0.34
2026-11-06ALDX0.6428.9- -0.34
2026-11-09ALDX0.6328.9- -0.34
2026-11-10ALDX0.6228.9- -0.34
2026-11-11ALDX0.6528.9- -0.34
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-10-13ALDX12.61-3.955.97
2026-10-14ALDX12.61-3.955.97
2026-10-15ALDX12.61-3.955.97
2026-10-16ALDX12.61-3.955.97
2026-10-19ALDX12.61-3.945.97
2026-10-20ALDX12.61-3.945.97
2026-10-21ALDX12.61-3.945.97
2026-10-22ALDX12.61-3.945.97
2026-10-23ALDX12.61-3.945.97
2026-10-26ALDX12.61-4.335.97
2026-10-27ALDX12.61-4.335.48
2026-10-28ALDX12.61-4.335.48
2026-10-29ALDX12.61-4.335.48
2026-10-30ALDX12.61-4.335.48
2026-11-02ALDX12.61-4.915.48
2026-11-03ALDX12.61-4.915.48
2026-11-05ALDX12.61-4.915.48
2026-11-06ALDX12.61-4.915.48
2026-11-09ALDX12.61-5.455.48
2026-11-10ALDX12.61-5.455.48
2026-11-11ALDX12.60-5.455.44
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

-0.09

Avg. EPS Est. Next Quarter

-0.1

Insider Transactions

12.6

Institutional Transactions

-5.45

Beta

1.27

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

20

Growth Score

19

Sentiment Score

26

Actual DrawDown %

94.6

Max Drawdown 5-Year %

-95.3

Target Price

6.6

P/E

Forward P/E

PEG

P/S

P/B

1.12

P/Free Cash Flow

EPS

-0.32

Average EPS Est. Cur. Y​

-0.34

EPS Next Y. (Est.)

-0.28

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

1.1

Return on Equity vs Sector %

-80.7

Return on Equity vs Industry %

-61.1

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ ALDX Healthcare
$0.65
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
2/20
Pullback
14/25
Volume
4/15
Valuation
12/20
TP/AR
2/10
Options
5/10
RSI
38
Range 1M
35.8%
Sup Dist
9%
🚀
Momentum Growth
Ride accelerating trends
N/A
27 /100
WEAK
Momentum
1/25
Growth
18/30
Estimates
0/20
Inst/Vol
2/15
Options
6/10
EPS Yr
43.6%
EPS NY
15.8%
52W%
2.7%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +915.4% upside
Quality
3/30
Valuation
16/30
Growth
13/25
Stability
7/10
LT Trend
1/5
Upside
+915.4%
Quality
20
ALDX — P/E HistoricalBiotechnology
Aldeyra Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 6
Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP) modulator, which is in Phase III clinical trial for the treatment of dry eye disease and allergic conjunctivitis; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment of primary vitreoretinal lymphoma and retinitis pigmentosa. The company also develops ADX-629, an orally administered RASP modulator that is in Phase 2 clinical trials for the treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication. In addition, it develops preclinical RASP platforms, including ADX 248, ADX 246, and other novel RASP modulators for the treatment of various diseases associated with RASP. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.
ALDX

Latest News

—
Caricamento notizie per ALDX…
stock quote shares ALDX – Aldeyra Therapeutics, Inc. Stock Price stock today
news today ALDX – Aldeyra Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ALDX – Aldeyra Therapeutics, Inc. yahoo finance google finance
stock history ALDX – Aldeyra Therapeutics, Inc. invest stock market
stock prices ALDX premarket after hours
ticker ALDX fair value insiders trading